Marker Therapeutics (MRKR) Current Leases (2019 - 2023)
Marker Therapeutics (MRKR) reported Current Leases of $665082.0 for Q1 2023, down 2.76% year-over-year from $683969.0 in Q1 2022, and up 15.23% quarter-over-quarter from $577198.0 in Q4 2022.
Marker Therapeutics (MRKR) Current Leases (2019 - 2023) Analysis & Trends
Marker Therapeutics (MRKR) has 5 years of Current Leases data on file, last reported at $665082.0 in Q1 2023.
- Current Leases for Q1 2023 came in at $665082.0, down 2.76% year-over-year; the trailing twelve-month figure through Mar 2023 was $665082.0 (down 2.76% YoY), and the FY2022 annual result was $577198.0, down 6.98% from the prior year.
- Current Leases improved to $665082.0 in Q1 2023 per MRKR's latest filing, from $577198.0 in the prior quarter.
- Over five years, Current Leases peaked at $738389.0 in Q2 2022 and troughed at $189791.0 in Q1 2019.
- A 5-year average of $441696.5 and a median of $473077.0 in 2021 frame the typical range for Current Leases.
- The sharpest annual moves came in 2020 and 2022: Current Leases jumped 134.5% in 2020, then decreased 15.67% in 2022.
- A 5-year view of Current Leases shows it stood at $204132.0 in 2019, then soared by 90.46% to $388792.0 in 2020, then jumped by 59.59% to $620490.0 in 2021, then fell by 6.98% to $577198.0 in 2022, then climbed by 15.23% to $665082.0 in 2023.
- Business Quant data shows MRKR's Current Leases at $665082.0 in Q1 2023, $577198.0 in Q4 2022, and $490449.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 665,082.00 |
| Dec 31, 2022 | 577,198.00 |
| Sep 30, 2022 | 490,449.00 |
| Jun 30, 2022 | 738,389.00 |
| Mar 31, 2022 | 683,969.00 |
| Dec 31, 2021 | 620,490.00 |
| Sep 30, 2021 | 581,588.00 |
| Jun 30, 2021 | 558,657.00 |
| Mar 31, 2021 | 473,077.00 |
| Dec 31, 2020 | 388,792.00 |
| Sep 30, 2020 | 278,333.00 |
| Jun 30, 2020 | 456,065.00 |
| Mar 31, 2020 | 209,081.00 |
| Dec 31, 2019 | 204,132.00 |
| Sep 30, 2019 | 199,266.00 |
| Jun 30, 2019 | 194,482.00 |
| Mar 31, 2019 | 189,791.00 |